Google Cloud 'can't wait to see what's next' as Servier extends AI drug R&D pact

Servier is extending its pact with Google Cloud as the French biopharma points to 60 examples of how generative artificial intelligence could improve its drug development processes.

The two companies initially signed a five-year pact in 2022 “aimed at deploying a robust technological structure within the Servier group to secure data and accelerate the deployment of initiatives such as AI.” But only two years in, Servier has already agreed to extend the collaboration for an additional five years.